Alignment Healthcare (NASDAQ:ALHC) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 26.32 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $692.43 million which beat the analyst consensus estimate of $662.10 million by 4.58 percent. This is a 51.61 percent increase over sales of $456.71 million the same period last year.